In the following sections, we will discuss the pathophysiology of major neurodegenerative diseases, AD, and PD, from the perspective of APOE’s non-protagonist role in pathophysiological processes (i.e., amyloid homeostasis, Tau phosphorylation, synuclein pathologies). This evidence concerns the gene MAPT and Alzheimer disease.